LEXINGTON, Mass., Aug. 8, 2012 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the 2012 Wedbush PacGrow Life Sciences Management Access Conference at 12:45 p.m. ET on August 15, 2012, in New York City.
